Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:45 AM
Ignite Modification Date:
2025-12-25 @ 1:45 AM
NCT ID:
NCT06148194
Eligibility Criteria:
Inclusion Criteria:
* Children (male/female) aged from 2 to 5 years, currently attending a preschool.
* Parents of the pediatric agree to participate in the study, explain, and sign the research consent form.
Exclusion Criteria:
* Children with a history of nasal reconstructive surgery, nasal ulcers, or nasal polyps.
* Children with a history of congenital immunodeficiency or infectious diseases (e.g., HIV).
* Children who regularly use products that may affect the research outcomes (e.g., immunosuppressive/immunostimulant drugs, pain relievers/anti-inflammatory drugs, anti-cough/expectorant drugs, antihistamines, or other probiotics) within 4 weeks before the start of the study.
* Children with co-morbidities that affect cognition and perception.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
2 Years
Maximum Age:
5 Years
Study:
NCT06148194
Study Brief:
Protocol Section:
NCT06148194